CONSOLIDATED STATEMENTS OF CASH FLOWS UNAUDITED (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Increase (decrease) in cash and cash equivalents of discontinued operations	$ 5,616	$ 1,717
Increase (decrease) in cash and cash equivalents of continuing operations	(9,014)	53,888
Cash flows from operating activities:
Net income (loss)	63,774	54,354
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	(136)	(6,040)
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation expense	13,934	13,137
Amortization expense	19,802	18,852
Changes in assets and liabilities, net of effects from acquisition and divestiture of businesses:
Accounts receivable, net of provision for doubtful accounts	(64,041)	17,640
Inventories	69,784	2,573
Other current and noncurrent assets	(4,450)	(9,330)
Accounts payable	54,154	(5,977)
Accrued employee compensation	(4,647)	(25,136)
Current and noncurrent liabilities	23,412	46,391
Net cash flows from operating activities of continuing operations	171,586	106,464
Net cash flows from operating activities of discontinued operations	5,912	2,431
Net cash flows from operating activities	177,498	108,895
Cash flows from investing activities:
Disposition of business, net	3,629	0
Capital expenditures	(26,165)	(22,415)
Other	12	854
Net cash flows used in investing activities of continuing operations	(22,524)	(21,561)
Net cash flows used in investing activities of discontinued operations	(296)	(714)
Net cash flows used in investing activities	(22,820)	(22,275)
Cash flows from financing activities:
Payments on Term Loans	(5,313)	(5,313)
Payments on long-term borrowings and obligations	(39,030)	(1,684)
Increase (decrease) in cash overdraft balance	(3,537)	(9,774)
Payments for Omnicare common stock repurchases	(95,417)	(302)
Proceeds for stock awards and exercise of stock options, net of stock tendered in payment	3,968	445
Dividends paid	(19,596)	(14,479)
Other	849	92
Net Cash Provided by (Used in) Financing Activities	(158,076)	(31,015)
Net increase (decrease) in cash and cash equivalents	(3,398)	55,605
Cash and cash equivalents at beginning of period	356,001	444,620
Cash and cash equivalents at end of period	$ 346,987	$ 498,508